Healthcare Stocks Are Looking Better But What About Biotech?

Image Source: 

Healthcare Stocks Are Looking Better

This is a momentum market so watch SMID biotechs for consistent rallies.

Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing.

Assuming a 5-10% correction healthcare may be less volatile than the S&P or Tech sector.

Healthcare stocks are looking better with the up 44 pts about 20%% off the November lows at $122.59. Of course if you’ve been trading tech stocks you barely noticed it because of the momentum in chip and software stocks. For example led by the AI theme chip stocks have been on a rampage over the past 6 months with Applied Materials ()  up 44.35%, Advanced Micro Devices (). up 62.21%, and NVDIA  () up 66.98%. And presumably unlike the tech stock run of 1999, this momentum has been driven by projected revenue growth as tech behemoths shift to the AI paradigm.AT the top down Indices level the is up 18.76 % over 6 months and 41.96% over one year.(Click on image to enlarge)
In contrast the health care and biotech sector performed as follows: up 7.57% over 6 mos yet only 2.76% in one year. up 19.3% over 6 mos and 9.89 % in one year. Bulish at breakthrough cusp. up 8.54% over 6 mos and 6.33% in one year.XLV up 8.23% over 6 mos and 11.31% in one year. our Favorite Fund is up 7% YTD,So clearly the healthcare is trending better led by large cap biopharmaceuticals with new blockbuster products and a revival in M&A. The XLV previously outperformed because of United Health (UNH) which tends to have consistent performance due to demographics and stable growth.. Lately however the performance of the XLV has improved because of large cap biopharma and medtech.In recent posts we covered healthcare funds, ETFs and  but if the Biotech Sector can recover it will require SMID stocks to regain momentm of 2022 highs. While this is hard to project or rationalize, it looks poised for a breakthrough at least for traders. But volatility can mask trends.We can look at  SMID biotech stocks broadly per the following subsectors: cellular therapy, diagnostics and tools, gene therapy, genomics and sequencing and immuno-oncology. And here is an updated list of SMID stocks and ETFs to watch or trade. We will update this list periodically with breaking news. We will focus in the coming weeks on genomics and gene therapy as well as some of the newer picks.Focus Stocks: , CRSPR, , , , , , .

    P 1/20/23 % Perf 2/4/23   12/24/23 Perf %           Company Ticker $   P % week P 4 wks YTD %   2/18/2024 YTD                       P %                             Acumen Therap ABOS     5.29   3.57 51.27 -33.89   3.28 -14.58   Catalyst Pharma CPRX     16.1 19.62 16.58 19.62 -10.86   14

-16.72

  Caribou Biosci CRBU NEW   6.29 20.55 6.17 8.44 -0.175   6.91 20.5   CorMedix CRMD NEW       3.9       3.3 -11.97   CRSPR Therap CRSP 49.61 -25 55.27 4.72 63.67 -9.68 56.63   82.22 31.34 u Cryoport CYRX 21.75 -42.34 25.24 9.41 16.09 14.76 -7.26   15.69 1.29   Evolent Health EVH 30.83 13.74 31.96 2.21 32.08 8.56 14.25   30.95 -6.3   Geron GERN 3.19 9.24 3.22 3.59 2.29 17.44 -5.37   2.01 -4.74   Hologic HOLX 79.66 22.41 84.68 2.28 71.04 -1.58 -5.04   73.79 3.29 h Illumina ILMN NEW       141       143.41 2.99   Immatics IMTX     9.3   9.9 20.88 13.66   11.67 10.83   Pacific Biosci PACB 11.29 55.68 11.58 -1.7 8.59 28.4 5   5.74 -28.62 d Quidel/Ortho QDEL 88.13 -11.56 89.7 3.93 73.98 7.19 -13.65   41.76 -43.34 sld Recursion Pharm RXRX NEW       10.75       13.15 33.37   Roivant ROIV NEW       11.4       11.59 3.21   Supernus SUPN 40.3 12.3 41.61 2.29 29.23 6.04 -18.05   28.42 2.95   Twist Biosci TWST   12/2 18   3.76 54.39 34.03   40.89 10.93 u 10x Genomics TXG   12/2 47.84   56.58 30.52 55.27   48.45 -13.42 d Vericel VCEL     31   34.75 -2.09 31.93   49.2 38.16 u Veracyte VCYT 24.89 39.43 26.67 2.46 28.27 8.23 19.13   24.74 -10                             SPDR Biotech XBI 86.99 14.75 90.39 1.12 87.62 20.36 5.57   93.15 4.32 u                                               P 2/18 %YTD   wildcard                         ArkGenomics ARKG NEW   35.28   32.81 18.88 16.22   31.4 -4.3 trde                           longs                         Becton-Dickinson BDX old pick add?             236.27 -1.26 long Cerevel CERE acquired ABBV             42.7 sold   Cytokinetics CYTK in play missed             85.6 out   Illumina ILMN redo               138.04 in               12/24/23             iShares CoreS&P IJR         108.34 12.96 14.48   107.38 -0.8   iShares Russell IWM         201.48 13.11 15.55   201.66 -0.47   iShares BIO IBB         133.77 12.68 -1.89   135.73 –   NASDAQ-100 QQQ         408.38 4.7 53.36   430.57 5.14 u HealthcareSPDR XLV         135.02 3.52 –   145.62 6.78 u                           T.RowePrice PRHSX         86.84 3.67 -3.32   94.19 7.16 u iShares MED Dev IHI         53.65 7.34 2.05   56.81 5,26 u

More By This Author:Healthcare And Life Science Funds And ETFs Performance 2023-2024Biotech And Medtech Portfolio Notes On A Fed Day Momentum Shifts Back To Tech Stocks As Healthcare Lags In 2024